Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
Research New Research Reveals How Seminal Fluid Actively Amplifies Mpox InfectivityGlobal Biodefense StaffSeptember 12, 2026
Defense + Military Pentagon Pain-Medication EUA Pathway Opens Amid Ongoing Iran ConflictGlobal Biodefense StaffSeptember 4, 2026
AbCellera and Eli Lilly to Co-Develop COVID-19 Therapeutic Antibodies Medical Countermeasures March 12, 2020 …
DARPA P3 Researchers Race to Create Treatment for the Novel Coronavirus Medical Countermeasures March 11, 2020 …
Critical Bioeconomy Asset in Need of Attention: BSL-3 and BSL-4 Laboratories in the U.S. Medical Countermeasures March 6, 2020 …
Passive Immunization with mAbs Against Aerosolized Ricin Toxin Medical Countermeasures March 6, 2020 …
Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform Medical Countermeasures March 3, 2020 …
CureVac CEO Discusses Coronavirus Vaccine Development with White House Leadership Medical Countermeasures March 3, 2020 …
Senator Markey Introduces Legislation to Invest $1 Billion in Universal Coronavirus Vaccine Medical Countermeasures March 2, 2020 …
Patients in Nebraska Part of First COVID-19 Clinical Trial in U.S. Medical Countermeasures February 25, 2020 …
University of Queensland COVID-19 Vaccine Goes Into Test Production Medical Countermeasures February 23, 2020 …
JLABS @ Washington DC Seeks Innovations for Pediatric Influenza Interventions Contracts + Grants February 22, 2020 …
Tulane National Primate Research Center Launches Coronavirus Research Program Medical Countermeasures February 21, 2020 …
Columbia University Researchers Awarded $2M to Identify Antiviral Drugs for Coronavirus Medical Countermeasures February 21, 2020 …
Columbia University Researchers Awarded $2 Million to Identify Antiviral Drugs for New Coronavirus Medical Countermeasures February 20, 2020 …
Synedgen to Present Data on Therapeutic for Ocular Mustard Gas Injury at NIH Meeting CBRNE February 19, 2020 …
Humanetics Corporation Acquires Manufacturing Assets for Radioprotectant Drug CBRNE February 19, 2020 …
NIH Study Supports New Approach for Treating Cerebral Malaria Infectious Diseases February 19, 2020 …
